Monogram Biosciences is a valued research partner committed to providing biopharmaceutical partners and research collaborators with clinical, scientific, and logistical support for critical drug development projects in human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and oncology via agreements, strategic alliances, and long-term alliances.
Neutralizing Antibody Assay Could Be Used to Assist in Development of COVID-19 Vaccines and Plasma-Based Treatments
The new test can be used to assess the capacity of antibodies in patient plasma to inhibit the SARS-CoV-2 virus. This information could be used in the development of COVID-19 vaccines and the screening of convalescent plasma for prophylactic and therapeutic use. This neutralizing antibody test will be available to biopharmaceutical companies, hospitals, blood banks and other plasma-screening facilities.
Monogram presents RSV assay data to assist vaccine development at RSV16:10th International Respiratory Syncytial Virus Symposium.
We offer the following:
Click on the link below to view Monogram Biosciences assays and services for supporting clinical trials, as well as, future areas of focus.